ZKB-24942-36487
3 vaccinations
1 coded response
18 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 223 / VA
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-04
Registered in v-safe
-
2021-01-04
Dose 1 — Pfizer-BioNTech
- 2021-01-04
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-18
- 2021-01-25
-
2021-01-29
Dose 2 — Pfizer-BioNTech
- 2021-02-22
- 2021-03-05
- 2021-03-12
- 2021-04-30
- 2021-07-30
-
2022-04-12
Dose 3 — Pfizer-BioNTech
- 2022-04-22
-
2022-04-26
Survey response — day 14, dose 3MedDRA: Fatigue, Heart rate increased, Upper respiratory tract congestion — Feeling: Good · Be unable to work or attend schoolFree text: Rapid heart rate, fatigue, upper airway congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-05-03
- 2022-05-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech | |
| 3 | 2022-04-12 | Pfizer-BioNTech | No |
Free text
Release 11 — day 14, dose 3
Symptoms: Rapid heart rate, fatigue, upper airway congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Upper respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release